Hodgkin Lymphoma: The Follow-Up of Long-Term Survivors

Hematology/Oncology Clinics of North America

Volumn 22, Issue 2, 2008, Pages 233-244

  Hodgson, David C ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; MENINGOCOCCUS VACCINE; METHYLPHENIDATE; MODAFINIL; PNEUMOCOCCUS VACCINE; PREDNISONE; PROCARBAZINE; THYROID HORMONE; VINBLASTINE; VINCRISTINE;

BREAST CANCER; CANCER FATIGUE; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; CANCER SURVIVOR; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DRUG DOSE ESCALATION; EVALUATION; FEMALE INFERTILITY; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; HYPOTHYROIDISM; INFERTILITY; INFLUENZA; INTERMETHOD COMPARISON; LUNG CANCER; LUNG FUNCTION TEST; MALE INFERTILITY; MAMMOGRAPHY; MENINGOCOCCOSIS; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT BLOOD TEST; OVARY INSUFFICIENCY; PNEUMONIA; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT DISEASE; REVIEW; SECOND CANCER; SIDE EFFECT; SIGMOIDOSCOPY; STREPTOCOCCUS INFECTION; STRESS ECHOCARDIOGRAPHY; SYMPTOM;

AFTERCARE; CARDIOVASCULAR DISEASES; HODGKIN DISEASE; HUMANS; NEOPLASMS, SECOND PRIMARY; PRACTICE GUIDELINES AS TOPIC; SURVIVORS;

EID: 41349084155     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2008.01.004     Document Type: Review

References (44)

1. van Spronsen D.J., Dijkema I.M., Vrints L.W., et al. Improved survival of Hodgkin's patients in south-east Netherlands since 1972. Eur J Cancer 33 3 (1997) 436-441
2. Kennedy B.J., Fremgen A.M., and Menck H.R. The national cancer data base report on Hodgkin's disease for 1985-1989 and 1990-1994. Cancer 83 5 (1998) 1041-1047
3. Hodgson D.C., Zhang-Salomons J., Rothwell D., et al. Evolution of treatment for Hodgkin's disease: a population-based study of radiation therapy use and outcome. Clin Oncol (R Coll Radiol) 15 5 (2003) 255-263
4. Skinner R., Wallace W.H., and Levitt G. Therapy based long term follow up: practice statement. UK children's cancer study group. Available at: (2005). http://www.ukccsg.org.uk/public/followup/PracticeStatement/index.html Accessed November 5, 2007
5. Scottish Intercollegiate Guidelines Network. Long term follow up of survivors of childhood cancer. Guideline no. 76. Available at: (2004). http://www.sign.ac.uk/pdf/sign76.pdf Accessed November 5, 2007
6. NCCN Clinical Practice Guidelines in Oncology. Hodgkin disease/lymphoma. Available at: (2007). http://www.nccn.org/professionals/physician_gls/PDF/hodgkins.pdf Accessed November 5, 2007
7. Children's Oncology Group. Long term follow-up guidelines. Available at: (2006). www.survivorshipguidelines.org Accessed November 5, 2007
8. Deming R.L., Constine L.S., Elman A.J., et al. Follow-up of Hodgkin's disease. American College of Radiology. ACR appropriateness criteria. Radiology 215 Suppl (2000) 1269-1279
9. Aleman B.M., van den Belt-Dusebout A.W., Klokman W.J., et al. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 21 18 (2003) 3431-3439
10. Hodgson D.C., Gilbert E.S., Dores G.M., et al. Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol 25 12 (2007) 1489-1497
11. Hoppe R.T. Hodgkin's disease: complications of therapy and excess mortality. Ann Oncol 8 (1997) 115-118
12. Travis L.B., Hill D.A., Dores G.M., et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290 4 (2003) 465-475
13. Swerdlow A.J., Schoemaker M.J., Allerton R., et al. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. J Clin Oncol 19 6 (2001) 1610-1618
14. Travis L.B., and Gilbert E. Lung cancer after Hodgkin lymphoma: the roles of chemotherapy, radiotherapy and tobacco use. Radiat Res 163 6 (2005) 695-696
15. Ralleigh G., and Given-Wilson R. Breast cancer risk and possible screening strategies for young women following supradiaphragmatic irradiation for Hodgkin's disease. Clin Radiol 59 8 (2004) 647-650
16. Lee L., Pintilie M., Hodgson D.C., et al. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma. Annals of Oncology 19 (2008) 62-67
17. Diller L., Medeiros Nancarrow C., Shaffer K., et al. Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study. J Clin Oncol 20 8 (2002) 2085-2091
18. Allen M., Ng A., Mauch P., et al. A decision and cost effectiveness analysis on tamoxifen as chemoprevention for breast cancer in young women treated with radiation therapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 54 Suppl 1 (2002) 11
19. Mauch P., Ng A., Aleman B., et al. Report from the Rockefeller foundation sponsored international workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease. European J Haemotol 75 Suppl 66 (2005) 68-76
20. Henschke C.I. CT screening for lung cancer is justified. Nat Clin Pract Oncol 4 8 (2007) 440-441
21. Gleeson F.V. Screening for lung cancer with spiral CT is not justified. Nat Clin Pract Oncol 4 8 (2007) 442-443
22. Das P., Ng A.K., Earle C.C., et al. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. Ann Oncol 17 5 (2006) 785-793
23. Abrams D.B., Raymond N., Richard A., et al. The tobacco dependence treatment handbook: a guide to best practices (2003), Guilford Press, New York
24. US Preventive Services Taskforce. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 137 2 (2002) 129-131
25. Colorectal cancer screening. Recommendation statement from the Canadian task force on preventive health care. CMAJ 165 2 (2001) 206-208
26. American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12 1 (2006) 63-102
27. Aleman B.M., van den Belt-Dusebout A.W., De Bruin M.L., et al. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109 5 (2007) 1878-1886
28. Hull M.C., Morris C.G., Pepine C.J., et al. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290 21 (2003) 2831-2837
29. Krischer J.P., Epstein S., Cuthbertson D.D., et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the pediatric oncology group experience. J Clin Oncol 15 4 (1997) 1544-1552
30. Lipshultz S.E., Lipsitz S.R., Sallan S.E., et al. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol 20 23 (2002) 4517-4522
31. Silber J.H., Cnaan A., Clark B.J., et al. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 22 5 (2004) 820-828
32. Heidenreich P.A., Schnittger I., Strauss H.W., et al. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J Clin Oncol 25 1 (2007) 43-49
33. Constine L.S., Donaldson S.S., McDougall I.R., et al. Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer 53 4 (1984) 878-883
34. Gharib H., Tuttle R.M., Baskin H.J., et al. Subclinical thyroid dysfunction: a joint statement on management from the American association of clinical endocrinologists, the American thyroid association, and the endocrine society. J Clin Endocrinol Metab 90 1 (2005) 581-585 [discussion: 586-7]
35. Hodgson D.C., Pintilie M., Gitterman L., et al. Fertility among female Hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol 25 1 (2007) 11-15
36. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services task force. Ann Intern Med 142 10 (2005) 855-860
37. Bilukha O.O., and Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 54 RR-7 (2005) 1-21
38. Uzel I., Ozguroglu M., Uzel B., et al. Delayed onset bleomycin-induced pneumonitis. Urology 66 1 (2005) 195e.23-195e.25
39. Huls G., and ten Bokkel Huinink D. Bleomycin and scuba diving: to dive or not to dive?. Neth J Med 61 2 (2003) 50-53
40. de Wit R., Sleijfer S., Kaye S.B., et al. Bleomycin and scuba diving: where is the harm?. Lancet Oncol 8 11 (2007) 954-955
41. Ganz P.A., and Bower J.E. Cancer related fatigue: a focus on breast cancer and Hodgkin's disease survivors. Acta Oncol 46 4 (2007) 474-479
42. Ganz P.A., Moinpour C.M., Pauler D.K., et al. Health status and quality of life in patients with early-stage Hodgkin's disease treated on southwest oncology group study 9133. J Clin Oncol 21 18 (2003) 3512-3519
43. Ng A.K., Li S., Recklitis C., et al. A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol 16 12 (2005) 1949-1955
44. Carroll J.K., Kohli S., Mustian K.M., et al. Pharmacologic treatment of cancer-related fatigue. Oncologist 12 Suppl 1 (2007) 43-51